These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8733746)

  • 1. Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A.
    Petitet F; Marin L; Doble A
    Neuroreport; 1996 Feb; 7(3):789-92. PubMed ID: 8733746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
    Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
    Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist.
    Hirst RA; Almond SL; Lambert DG
    Neurosci Lett; 1996 Dec; 220(2):101-4. PubMed ID: 8981483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.
    Rinaldi-Carmona M; Barth F; Héaulme M; Alonso R; Shire D; Congy C; Soubrié P; Brelière JC; Le Fur G
    Life Sci; 1995; 56(23-24):1941-7. PubMed ID: 7776817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.
    Griffin G; Wray EJ; Martin BR; Abood ME
    Br J Pharmacol; 1999 Oct; 128(3):684-8. PubMed ID: 10516649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.
    Petitet F; Jeantaud B; Capet M; Doble A
    Biochem Pharmacol; 1997 Dec; 54(11):1267-70. PubMed ID: 9416978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM; Paria BC; Dey SK
    Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
    Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
    Houston DB; Howlett AC
    Cell Signal; 1998 Oct; 10(9):667-74. PubMed ID: 9794249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Héaulme M; Shire D; Calandra B; Congy C; Martinez S; Maruani J; Néliat G; Caput D
    FEBS Lett; 1994 Aug; 350(2-3):240-4. PubMed ID: 8070571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
    Stark S; Pacheco MA; Childers SR
    Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid penetration into mouse brain as determined by ex vivo binding.
    Petitet F; Jeantaud B; Bertrand P; Imperato A
    Eur J Pharmacol; 1999 Jun; 374(3):417-21. PubMed ID: 10422786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
    Breivogel CS; Sim LJ; Childers SR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1632-42. PubMed ID: 9316881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
    Devlin MG; Christopoulos A
    J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
    Kathmann M; Bauer U; Schlicker E; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
    Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
    Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
    Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
    Niederhoffer N; Szabo B
    J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.